UroGen Pharma Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Holden Stuart | — | Option Exercise | 2,000 | — | — | 2,000 | Nov 26, 2025 |
| BUTITTA CYNTHIA M | — | Option Exercise | 2,000 | — | — | 2,000 | Nov 26, 2025 |
| Robinson James A. Jr. | — | Option Exercise | 2,000 | — | — | 2,000 | Nov 26, 2025 |
| WEN LEANA | — | Option Exercise | 2,000 | — | — | 2,000 | Nov 26, 2025 |
| Wildman Daniel George | — | Option Exercise | 2,000 | — | — | 2,000 | Nov 26, 2025 |
| Schoenberg Mark | Chief Medical Officer | Sale | 10,000 | $25.00 | $250,000 | 139,025 | Nov 19, 2025 |
| Degnan Chris | Chief Financial Officer | Sale | 2,203 | $16.85 | $37,121 | 2,280 | Oct 8, 2025 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 1,667 | — | — | 149,896 | Sep 8, 2025 |
| Smith Jason Drew | General Counsel | Option Exercise | 3,333 | — | — | 44,825 | Sep 8, 2025 |
| Schoenberg Mark | Chief Medical Officer | Sale | 10,000 | $17.69 | $176,900 | 148,229 | Aug 11, 2025 |
| Smith Jason Drew | General Counsel | Option Exercise | 16,500 | — | — | 49,014 | Jul 28, 2025 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 10,000 | — | — | 163,378 | Jul 28, 2025 |
| Schoenberg Mark | Chief Medical Officer | Sale | 5,162 | $7.37 | $38,044 | 153,378 | Jun 8, 2025 |
| Schoenberg Mark | Chief Medical Officer | Sale | 1,896 | $11.14 | $21,121 | 148,540 | Jan 31, 2025 |
| Smith Jason Drew | General Counsel | Option Exercise | 5,500 | — | — | 35,281 | Jan 31, 2025 |
| Schoenberg Mark | Chief Medical Officer | Sale | 859 | $13.08 | $11,236 | 145,091 | Sep 9, 2024 |
| Smith Jason Drew | General Counsel | Sale | 1,521 | $13.08 | $19,895 | 25,226 | Sep 9, 2024 |
| Kim Dong | Chief Financial Officer | Option Exercise | 2,500 | — | — | 37,753 | Sep 9, 2024 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 10,000 | — | — | 149,437 | Jun 10, 2024 |
| Schoenberg Mark | Chief Medical Officer | Sale | 12,000 | $14.05 | $168,600 | 139,437 | Mar 18, 2024 |
| Smith Jason Drew | General Counsel | Sale | 1,248 | $15.78 | $19,693 | 20,076 | Feb 1, 2024 |
| Schoenberg Mark | Chief Medical Officer | Sale | 758 | $15.78 | $11,961 | 149,998 | Feb 1, 2024 |
| Kim Dong | Chief Financial Officer | Option Exercise | 3,333 | — | — | 35,253 | Jan 31, 2024 |
| Smith Jason Drew | General Counsel | Option Exercise | 2,500 | — | — | 21,324 | Jan 31, 2024 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 3,333 | — | — | 153,331 | Jan 31, 2024 |
| Kim Dong | Chief Financial Officer | Option Exercise | 3,333 | — | — | 26,585 | Jan 31, 2024 |
| Smith Jason Drew | General Counsel | Option Exercise | 8,334 | — | — | 22,207 | Aug 31, 2023 |
| Cohen Fred E | — | Award / Grant | 69,339 | $9.54 | $661,494 | 69,339 | Jul 26, 2023 |
| Barrett Elizabeth A. | Chief Executive Officer | Option Exercise | 5,000 | — | — | 313,358 | Jan 31, 2023 |
| Smith Jason Drew | General Counsel | Option Exercise | 833 | — | — | 13,009 | Jan 31, 2023 |
| Schoenberg Mark | Chief Medical Officer | Sale | 248 | $10.12 | $2,510 | 146,879 | Jan 31, 2023 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 122,677 | $5.00 | $613,385 | 146,627 | Jan 20, 2023 |
| Schoenberg Mark | Chief Medical Officer | Sale | 258 | $11.85 | $3,057 | 23,950 | Oct 31, 2022 |
| Nussbaum Ran | — | Option Exercise | 47,999 | $5.94 | $285,114 | 1,481,927 | Oct 21, 2022 |
| Nussbaum Ran | — | Option Exercise | 47,999 | $5.94 | $285,114 | 1,485,168 | Oct 21, 2022 |
| Belldegrun Arie | — | Option Exercise | 160,000 | $5.00 | $800,000 | 408,693 | Sep 14, 2022 |
| Belldegrun Arie | — | Option Exercise | 3,241 | $5.00 | $16,205 | 248,693 | Aug 31, 2022 |
| Smith Jason Drew | General Counsel | Option Exercise | 8,333 | — | — | 15,782 | Aug 31, 2022 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 500 | — | — | 23,967 | Aug 1, 2022 |
| Nussbaum Ran | — | Option Exercise | 2,211 | $5.00 | $11,055 | 1,437,169 | Jun 16, 2022 |
| Nussbaum Ran | — | Option Exercise | 1,030 | $5.00 | $5,150 | 1,434,958 | Jun 6, 2022 |
| Nussbaum Ran | — | Option Exercise | 1,030 | $5.00 | $5,150 | 1,433,928 | Jun 6, 2022 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 500 | — | — | 23,721 | Apr 30, 2022 |
| Smith Jason Drew | General Counsel | Sale | 414 | $7.58 | $3,138 | 7,449 | Jan 31, 2022 |
| Henderson Molly | Chief Financial Officer | Option Exercise | 666 | — | — | 5,579 | Jan 31, 2022 |
| Schoenberg Mark | Chief Medical Officer | Option Exercise | 2,000 | — | — | 24,320 | Jan 31, 2022 |
| Barrett Elizabeth A. | Chief Executive Officer | Option Exercise | 13,333 | — | — | 314,318 | Jan 31, 2022 |
| Schoenberg Mark | Chief Medical Officer | Sale | 111 | $8.09 | $898 | 22,095 | Jan 26, 2022 |
| Barrett Elizabeth A. | Chief Executive Officer | Sale | 46,968 | $9.15 | $429,757 | 298,220 | Jan 3, 2022 |
| Smith Jason Drew | General Counsel | Sale | 3,803 | $12.03 | $45,750 | 7,030 | Nov 30, 2021 |